<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Dibucaine: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Dibucaine: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Dibucaine: Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="8894" href="/d/html/8894.html" rel="external">see "Dibucaine: Drug information"</a> and <a class="drug drug_patient" data-topicid="11937" href="/d/html/11937.html" rel="external">see "Dibucaine: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F159194"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Nupercainal (Topical) [OTC] [DSC];</li>
<li>Nupercainal [OTC]</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F1057807"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Analgesic, Topical</span>;</li>
<li>
<span class="list-set-name">Local Anesthetic, Topical</span></li></ul></div>
<div class="block dop drugH1Div" id="F159199"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="6c422237-3bb9-42a1-8a35-64487e916aaa">Dermal pain/itching</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Dermal pain/itching:</b> Children ≥2 years weighing ≥16 kg and Adolescents: Topical: Apply to affected area up to 3 or 4 times daily. Maximum daily dose: 7.5 g/<b>day</b> for children and 30 g/<b>day</b> for adults</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="342926a7-7dd9-4864-901e-d7a3f40ec1c5">Hemorrhoids/anorectal disorders; rectal pain/itching</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Hemorrhoids/anorectal disorders; rectal pain/itching:</b> Children ≥12 years and Adolescents: Topical: Apply to affected external anal area up to 3 or 4 times daily</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51109217"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block dohp drugH1Div" id="F51109218"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block doa drugH1Div" id="F159195"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="8894" href="/d/html/8894.html" rel="external">see "Dibucaine: Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="6c422237-3bb9-42a1-8a35-64487e916aaa">Dermal pain/itching</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Dermal pain/itching:</b>
<b>Topical:</b> Apply to affected area up to 3 or 4 times daily. Maximum daily dose: 30 g/<b>day</b>.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="93c6026c-8da1-4676-a6b0-f8bf5611d875">Hemorrhoids, anorectal pain/itch</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Hemorrhoids, anorectal pain/itch:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Combine with dietary modifications, bowel hygiene, and warm sitz baths for best results (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-29420423','lexi-content-ref-35119707']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-29420423','lexi-content-ref-35119707'])">Ref</a></span>). General dosing guidelines provided; refer to specific product labeling for dosing instructions.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Topical </b>(external): Apply to anal area, as needed, up to 4 times daily.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50989969"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F50987302"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F159176"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">There are no adverse reactions listed in the manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing: Dermatologic: Acute generalized exanthematous pustulosis (Cubero 2010), allergic dermatitis (including contact dermatitis, maculopapular rash, and symmetrical drug-related intertriginous and flexural exanthema [SDRIFE]) (de Groot 2022)</p></div>
<div class="block coi drugH1Div" id="F159187"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">OTC labeling: When used for self-medication, do not use in or near the eyes or in children &lt;2 years or weight &lt;16 kg.</p></div>
<div class="block war drugH1Div" id="F9775239"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Concerns related to adverse effects:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Methemoglobinemia: Has been reported with local anesthetics; clinically significant methemoglobinemia requires immediate treatment along with discontinuation of the anesthetic and other oxidizing agents. Onset may be immediate or delayed (hours) after anesthetic exposure. Patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, exposure to oxidizing agents or their metabolites, or infants &lt;6 months of age are more susceptible and should be closely monitored for signs and symptoms of methemoglobinemia (eg, cyanosis, headache, rapid pulse, shortness of breath, lightheadedness, fatigue).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Self-medication (OTC use): For external use only. When used for self-medication, notify health care provider and discontinue use if condition worsens, does not improve within 7 days, or if redness, irritation, swelling, bleeding, or other symptoms develop or increase. Do not put this product into the rectum using fingers or any mechanical device or applicator; do not exceed recommended dose unless directed by a health care provider. Do not use in large quantities, particularly over raw surfaces or blistered areas.</p>
<p style="text-indent:-2em;margin-left:4em;">• Topical application: When topical anesthetics are used prior to cosmetic or medical procedures, the lowest amount of anesthetic necessary for pain relief should be applied. High systemic levels and toxic effects (eg, methemoglobinemia, irregular heart beats, respiratory depression, seizures, death) have been reported in patients who (without supervision of a trained professional) have applied topical anesthetics in large amounts (or to large areas of the skin), left these products on for prolonged periods of time, or have used wraps/dressings to cover the skin following application.</p></div>
<div class="block foc drugH1Div" id="F159183"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Ointment, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Nupercainal: 1% (28.4 g, 60 g)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Nupercainal (Topical): 1% (56.7 g [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1% (28 g, 28.35 g, 56 g)</p></div>
<div class="block geq drugH1Div" id="F159170"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F7281364"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Ointment</b> (Dibucaine (Perianal) External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $0.14</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Ointment</b> (Dibucaine External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $0.21 - $0.24</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Ointment</b> (Nupercainal External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $0.18</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block admp drugH1Div" id="F52612539"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">For external use only. </p>
<p style="text-indent:-2em;margin-left:2em;">Rectal use: Clean the affected area with mild soap and warm water and rinse thoroughly; gently dry by patting or blotting with toilet tissue or a soft cloth. Do not put this product into the rectum using fingers or any mechanical device or applicator.</p>
<p style="text-indent:-2em;margin-left:2em;">Topical dermal use: Do not use in or around eyes. Do not use in large quantities, particularly over raw surfaces or blistered areas.</p></div>
<div class="block adm drugH1Div" id="F44945076"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">Topical: For external use only; do not use in or around eyes. Prior to rectal use, clean the affected area with mild soap and warm water and rinse thoroughly; gently dry by patting or blotting with toilet tissue or a soft cloth. Do not put this product into the rectum using fingers or any mechanical device or applicator.</p></div>
<div class="block sts drugH1Div" id="F159193"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;display:inline">Store at 20°C to 25°C (68°F to 77°F).</p></div>
<div class="block usep drugH1Div" id="F53566465"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">Temporary relief of pain and itching caused by sunburn, minor burns, minor cuts, scrapes, insect bites, or minor skin irritation (OTC product: FDA approved in ages ≥2 years weighing ≥16 kg and adults); temporary relief of pain and itching due to hemorrhoids or other anorectal disorders (OTC product: FDA approved in ages ≥12 years and adults) </p></div>
<div class="block cyt drugH1Div" id="F13299181"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F159177"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Methemoglobinemia Associated Agents: May enhance the adverse/toxic effect of Local Anesthetics. Specifically, the risk for methemoglobinemia may be increased.<i> Risk C: Monitor therapy</i></p></div>
<div class="block pha drugH1Div" id="F159173"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Blocks both the initiation and conduction of nerve impulses by decreasing the neuronal membrane's permeability to sodium ions, which results in inhibition of depolarization with resultant blockade of conduction.</p></div>
<div class="block phk drugH1Div" id="F45789740"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Onset of action: Within 15 minutes.</p>
<p style="text-indent:-2em;margin-left:2em;">Duration: 2 to 4 hours.</p>
<p style="text-indent:-2em;margin-left:2em;">Absorption: Poor through intact skin, but well absorbed through mucous membranes and excoriated skin.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F6875316"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Nupercainal</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Nupercainal</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Doloposterine n</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Neocaine</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Nupercainal</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Nupercainal</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Hemorrhoidal and topical analgesic ointment dibucaine</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Cinchocain</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Cinchocain</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Cinchocaine</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Dibucaine | Nupercainal hc</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Nupercainal</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Cincain</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Nupercainal</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Anesin | Dibuton | Jojo | Nupercainal</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Nupercainal</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-35119707">
<a name="35119707"></a>Brown S, Girling C, Thapa Magar H, et al. Guidelines, guidelines and more guidelines for haemorrhoid treatment: a review to sort the wheat from the chaff. <i>Colorectal Dis</i>. 2022;24(6):764-772. doi:10.1111/codi.16078<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/dibucaine-pediatric-drug-information/abstract-text/35119707/pubmed" id="35119707" target="_blank">35119707</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21314006">
<a name="21314006"></a>Cubero JL, Garcés MM, Segura N, et al. Topical drug-induced acute generalized exanthematous pustulosis misdiagnosed as an oral drug-related eruption. <i>J Investig Allergol Clin Immunol</i>. 2010;20(7):620-621.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/dibucaine-pediatric-drug-information/abstract-text/21314006/pubmed" id="21314006" target="_blank">21314006</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29420423">
<a name="29420423"></a>Davis BR, Lee-Kong SA, Migaly J, Feingold DL, Steele SR. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the management of hemorrhoids. <i>Dis Colon Rectum</i>. 2018;61(3):284-292. doi:10.1097/DCR.0000000000001030<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/dibucaine-pediatric-drug-information/abstract-text/29420423/pubmed" id="29420423" target="_blank">29420423</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34837391">
<a name="34837391"></a>de Groot AC. Systemic allergic dermatitis (systemic contact dermatitis) from pharmaceutical drugs: a review. <i>Contact Dermatitis</i>. 2022;86(3):145-164. doi:10.1111/cod.14016<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/dibucaine-pediatric-drug-information/abstract-text/34837391/pubmed" id="34837391" target="_blank">34837391</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Dibucaine ointment [prescribing information]. Allegan, MI: Perrigo; July 2014.</div>
</li>
<li>
<div class="reference">
                  Dibucaine ointment [prescribing information]. Melville, NY: Fougera; December 2011.</div>
</li>
<li>
<div class="reference">
                  Nupercainal ointment (dibucaine) [prescribing information]. Princeton, NJ: Dr. Reddy's Laboratories, Inc; received 2016.</div>
</li></ol></div><div id="topicVersionRevision">Topic 13225 Version 153.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
